Langlui's Big Board and Options Plays

[langlui]

ups and downs 8-15 ~ ALVR +120%, BIOL +38%

Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz2c2yYSyJf
09:23 SVA Sinovac Biotech follow-up; upgraded to Buy from Hold at Aegis Capital following earnings; tgt $7 (4.57 )

Sinovac's EV71 vaccine could be approved in late 2013 or early 2014 and could start to be marketed in early to mid-2014, in our view.


Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz2c2x372z0
Under Creative Commons License: Attribution

8:58 SUMRX Gapping up/down: A +3% and KSS +1% following earnings, VLTR +54% following MXIM acquisition of co for $23/shr, JKS +5% on upgrade; CSCO -8% and PRGO -3% following earnings, Metals and miners trading lower, SWHC -2.5% on dg

Gapping up
In reaction to strong earnings/guidance: SPPR +11%, (also announced 1-for-8 reverse stock split;) DDS +6.9%, NTES +5.9%, EARN +4.8%, A +3.8%, EL +2.1%, GK +1.7%, KSS +1.3%, SA +1%.

M&A news: VLTR +54.1% (to be acquired by Maxim Integrated (MXIM) for $23/share), SIRI +0.5% (enters into a definitive agreement to acquire the connected vehicle services business of Agero for $530 mln in cash.

Other news: ALVR +122.7% (Globes story on SuperCom / OTIV news mentions Sigma Wave interest in ALVR), BIOL +21.7% (to reduce total offering on Form S-3 to $5 mln from $30 mln; CEO says company is not in a liquidity crunch), XGTI +13.8%, (still checking), INO +9.9% (malaria DNA vaccine demonstrates robust immune responses in animal models), SPEX +5.9% (retains the law firm of Skiermont Puckett to lead the commercialization effort of the co's patent portfolio acquired from Rockstar), FFHL +5.8% (announces receipt of notice of proposed public auction of controlling interest), RAD +2.9% (Greenlight Capital takes a share stake of 20.2 mln), JCP +1.6% (DailyMail discusses speculation that Bill Ackman will soon be working with PE firms to take JCP private at 'substantial premium', while George Soros wants to double his stake), DF +1.5% (announced 1-for-2 reverse stock split), MPWR +1.4% (Federal Circuit upholds $9.5 mln attorneys' fee and cost award to MPWR).

Analyst comments: NVAX +16.7% (tgt raised to $11 from $4 at Lazard), JKS +4.9% (upgraded to Buy from Neutral at ROTH Capital), MMLP +0.8% (upgraded to Outperform from Market Perform at Raymond James).

Gapping down
In reaction to disappointing earnings/guidance: VIPS -12.4%, CSCO -8.2%, DANG -6%, NTAP -5.5%, AVNW -4.7%, HIMX -4.5%, CYCC -4.4%, TROV -4.4%, LWAY -4.1%, PRGO -3.5%, GALT -3.4%, WMT -2.3%, HTM -1.7%, PAAS -0.8%.

M&A news: ONXX -3.8% (lower on reports of stalled merger with AMGN).

Select metals/mining stocks trading lower: HMY -4.6%, GFI -3.2%, CLF -2.3%, RIO -1.8%, IAG -1.7%, EGO -1.5%, X -1.5%, IAG -1.4%, AKS -1.4%, GDX -1.1%, GLD -1.1%, AG -0.8%.

Other news: MPW -5.7% (Announces Public Offerings of 10 mln shares of Common Stock and $150 mln of Senior Notes due 2022), OWW -3.5% (insider selling by Dir and 10% owner), JNPR -2.4% (following CSCO results), AZN -1.7% (downgraded intraday yesterday, likely follow through since EU mkts were closed), HPQ -1.4% (still checking), TXN -1.2% (following CSCO results).

Analyst comments: SWHC -2.5% (downgraded to Underweight from Hold at KeyBanc Capital Mkts), MT -1.8% (initiated with a Underweight at Barclays), MU -1.8% (downgraded to Neutral from Outperform at Robert W. Baird), INTC -1.1% (downgraded to Neutral from Outperform at Robert W. Baird).